↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

270 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   7-beta-Hydroxyepiandrosterone  1件: 7-beta-hydroxyepiandrosterone;   -   -   -   1件:
6
 2   ACR325  1件: Acr325;   -   -   -   1件:
6
 3   AV-101  1件: Av-101;   -   -   -   1件:
6
 4   Acamprosate  1件: Acamprosate;   D02780
 D07058 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   4件: Alcoholism, Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
206
 5   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 6   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 7   Acetylcysteine  8件: Acetylcysteine; N-acetylcysteine; N-acetylcysteine capsule; Glatiramer acetate, n-acetylcysteine; N acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine, (nac); Acetylcysteine sodium;   D00221   -   -   16件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
96,
97,
111,
164,
233,
298,
299
 8   Activated charcoal  0件:   D03251   -   -   8件:
6,
13,
46,
85,
86,
96,
97,
298
 9   Ademetionine  0件:   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172
 10   Agomelatine  2件: Agomelatine; Agomelatine or piacebo;   D02578   3件: HTR2C, MTNR1A, MTNR1B   3件: Circadian entrainment, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6
 11   Allopurinol  4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol;   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97
 12   Altropane  2件: Altropane; Altropane®;   -   -   -   1件:
6
 13   Amantadine  10件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hydrochloride; Amantadine sulfate; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj;   D00777
 D07441 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   4件:
6,
8,
13,
127
 14   Ambroxol  2件: Ambroxol; Ambroxol hydrochloride;   D07442   -   -   2件:
6,
19
 15   Amoxicillin  7件: Amoxicillin; Clartihromycin, amoxicillin, and omeprazole; Amoxicillin hydrate; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline; Lansoprazole, amoxicillin, clarithromycin;   D00229
 D02925
 D07452 
 -   -   6件:
6,
46,
63,
96,
97,
222
 16   Aplindore  2件: Aplindore; Aplindore mr tablets;   -   -   -   1件:
6
 17   Apomorphine  19件: 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate; 6aß - apomorphine-10,11-diol hydrochloride hemihydrate; Apomorphine; Apomorphine 0.25% (2.5mg/ml); Apomorphine hcl injection; Apomorphine hydrochloride; Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed; Apomorphine hydrocloride; Apomorphine hydrocloride hemihydrate; Apomorphine infusion; Apomorphine nasal powder; Dopaminergic agonist + apomorphine; Injection of apomorphine; Iv apomorphine; S.c. apomorphine; Subcutaneous apomorphine;   D02004
 D07460 
 2件: DRD1, DRD2   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   1件:
6
 18   Aripiprazole  1件: Aripiprazole;   D01164   4件: DRD2, DRD3, HTR1A, HTR2A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
6,
206
 19   Armodafinil  1件: Armodafinil;   D03215   1件: SLC6A3   1件: Dopaminergic synapse   3件:
6,
13,
84
 20   Atomoxetine  1件: Atomoxetine;   D02574
 D07473 
 1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13
 21   Bavisant  3件: Bavisant; Bavisant dihydrochloride monohydrate; Bavisant hydrochloride monohydrate;   D09870   -   -   1件:
6
 22   Benserazide  8件: Benserazide; Benserazide hydrochloride; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa/benserazide; Levodopa/benserazide 100/25 mg;   D03082   1件: DDC   2件: Dopaminergic synapse, Serotonergic synapse   1件:
6
 23   Benzofuran  2件: Benzofuran; R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride;   -   -   -   1件:
6
 24   Bifenthrin  0件:   -   -   -   2件:
6,
46
 25   Botulinum Toxin Type B  3件: Botulinum toxin type b; Botulinum toxin type b (myobloc); Botulinum toxin type b (2500 units / vial);   D02735   1件: SNAP25   1件: Synaptic vesicle cycle   3件:
2,
6,
51
 26   Botulinum toxin type A  3件: Botulinum toxin type a; Clostridium botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle;   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   13件:
2,
5,
6,
7,
13,
15,
17,
36,
51,
70,
113,
149,
226
 27   Bromocriptine  2件: Bromocriptine; Bromocriptine and other dopamine agonists;   D00780
 D03165 
 2件: DRD2, PRL   4件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease, Prolactin signaling pathway   2件:
6,
74
 28   Bumetanide  2件: Bumetanide; Bumetanide white, oblong, scored tablet;   D00247   -   -   2件:
6,
158
 29   Buspirone  2件: Buspirone; Buspirone hydrochloride;   D00702
 D07593 
 2件: DRD2, HTR1A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
6,
51
 30   Butylphthalide  1件: Butylphthalide;   -   -   -   2件:
2,
6
 31   CEP-1347  3件: Cep-1347; Cep-1347 10mg; Cep-1347 50mg;   -   -   -   1件:
6
 32   Cabergoline  2件: Cabergoline; Pasireotide with or without cabergoline;   D00987   2件: DRD2, PRL   4件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease, Prolactin signaling pathway   3件:
6,
74,
75
 33   Caffeine  5件: Caffeine; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Caffeine 100 mg;   D00528
 D01453 
 9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   6件:
2,
6,
46,
78,
96,
97
 34   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 35   Cannabidiol  6件: Cannabidiol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol tablet 10 mg; Cannabidiol (cbd); Cannabidiol oral solution;   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 36   Capsaicin  4件: Capsaicin; Capsaicin challenge; Capsaicin vapor; Qutenza (8% capsaicin);   D00250   1件: TRPV1   1件: Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226
 37   Carbidopa  60件: Carbidopa; Carbidopa-levodopa; Accordion pill carbidopa/levodopa; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa 20 mg; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa fu; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Entacapone and carbidopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 25/100 mg; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Xp21279 and carbidopa (experimental); Levodopa/carbidopa (4:1);   D00558   1件: DDC   2件: Dopaminergic synapse, Serotonergic synapse   8件:
2,
4,
6,
13,
17,
90,
164,
201
 38   Carnosine  3件: Carnosine; Carnosine supplementation; Carnosine, capsulle, 2 g/day, 8 weeks;   -   -   -   2件:
6,
13
 39   Carvedilol  2件: Carvedilol; Spironolactone captopril carvedilol;   D00255
 D03415 
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
6,
57,
86,
113
 40   Ceftriaxone  1件: Ceftriaxone;   D00924
 D07659 
 -   -   3件:
2,
6,
97
 41   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 42   Chloroxylenol  0件:   D03473   -   -   4件:
6,
13,
46,
168
 43   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 44   Clarithromycin  6件: Clarithromycin; Lansoprazole, clarithromycin, amoxycillin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Rifabutin, clarithromycin, and clofazimine; Lansoprazole, amoxicillin, clarithromycin; Biaxin ( clarithromycin);   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299
 45   Clonazepam  1件: Clonazepam;   D00280   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 46   Clonidine  3件: Clonidine; Clonidine hydrochloride; Clonidine hcl cf 0,150 mg, tabletten;   D00281
 D00604 
 3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
6,
78
 47   Clozapine  1件: Clozapine;   D00283   11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6
 48   Cobalt chloride  0件:   -   -   -   1件:
6
 49   Cocoa  3件: Cocoa; Dark chocolate (85% cocoa); White chocolate (0% cocoa);   -   -   -   1件:
6
 50   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 51   Cyanocobalamin  0件:   D00166
 D03615
 D03616
 D03617 
 -   -   12件:
6,
13,
49,
62,
86,
96,
97,
201,
229,
254,
284,
299
 52   D-Serine  2件: D-serine; D-serine (~2g/day);   -   -   -   1件:
6
 53   D-glucose  3件: 2-deoxy-2 [f-18] fluoro-2-d-glucose; D-glucose; [18f]fluoro-2-deoxy-2-d-glucose;   D00009   -   -   6件:
6,
13,
49,
86,
88,
299
 54   Darifenacin  2件: Darifenacin; Oxybutynin and darifenacin;   D01699
 D03654 
 1件: CHRM3   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
13
 55   Date  6件: Date; Methylphenidate; Methylphenidate (mpd); Methylphenidate hydrochloride; Phosphorodiamidate morpholino oligomer; Phosphorodiamidate morpholino oligomer for exon 53 skipping;   -   -   -   3件:
6,
88,
113
 56   Deanol  2件: Deanol; Deanol pyroglutamate;   D07777   -   -   1件:
6
 57   Deferiprone  7件: Deferiprone; Deferiprone (ferriprox); Deferiprone 600 mg delayed release tablet; Ferrprox (deferiprone); Deferiprone 80 mg/ml oral solution; Deferiprone 80 mg/ml oral solution (ferriprox); Deferiprone oral solution;   D07416   -   -   5件:
2,
6,
120,
122,
233
 58   Desmopressin  9件: Desmopressin; Desmopressin acetat; Desmopressin acetate; Desmopressin intranasal; Desmopressin oral melt; Desmopressin acetate trihydrate; Desmopressine; Desmopressine nasal spray 10 mg/ml, flacon 60 doses; Ddavp (desmopressin);   D00291
 D02235 
 2件: AVPR2, F8   3件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption   6件:
6,
64,
72,
75,
225,
288
 59   Dexmedetomidine  8件: Dexmedetomidine; Dexmedetomidine hydrochloride infusion; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine and fentanyl; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3;   D00514
 D01205 
 3件: ADRA2A, ADRA2B, ADRA2C   1件: Neuroactive ligand-receptor interaction   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280
 60   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 61   Dihydrotachysterol  0件:   D00299   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
6
 62   Dipivefrin  2件: Dipivefrin; Dipivefrine;   D02349   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   1件:
6
 63   Dipraglurant  1件: Dipraglurant;   -   -   -   1件:
6
 64   Doconexent  0件:   -   -   -   7件:
6,
49,
90,
94,
240,
299,
301
 65   Domperidone  3件: Domperidone; Domperidone (drug); Levodopa and domperidone;   D01745
 D07868 
 1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
13,
17,
51,
230
 66   Donepezil  4件: Donepezil; Donepezil sandoz; Donepezil hci (drug); Donepezil hydrochloride;   D00670
 D07869 
 1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206
 67   Dopamine  11件: Bromocriptine and other dopamine agonists; Cerebral dopamine neurotrophic factor; Continuous release dopamine agonists; Dopamine; Dopamine agent; Dopamine agonists (pramipexole, ropirinole); Dopaminergic agonist + apomorphine; Dopaminergic agonists; Recombinant human cerebral dopamine neurotrophic factor; Dopamine agonist treatment; Dopamine agonists;   D00633
 D07870 
 5件: DRD1, DRD2, DRD3, DRD4, DRD5   3件: Calcium signaling pathway, Dopaminergic synapse, Neuroactive ligand-receptor interaction   3件:
6,
7,
74
 68   Doxepin  2件: Doxepin; Doxepin and zopiclone;   D00814
 D07875 
 3件: HRH1, SLC6A2, SLC6A4   4件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle   1件:
6
 69   Droxidopa  1件: Droxidopa;   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   3件:
5,
6,
17
 70   Duloxetine  3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci);   D01179
 D07880 
 2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49
 71   Eliprodil  1件: Eliprodil;   -   -   -   1件:
6
 72   Eltoprazine  3件: Eltoprazine; Eltoprazine hcl; Eltoprazine hydrochloride;   -   -   -   1件:
6
 73   Entacapone  12件: Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa, levodopa, entacapone; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa/entacapone; Entacapone; Entacapone and carbidopa; Levodopa, carbidopa, entacapone; Levodopa-carbidopa-entacapone; Levodopa/carbidopa/entacapone; Over-encapsulated entacapone tablets; Stalevo (levodopa/ carbidopa/ entacapone); V1512 and entacapone;   D00781   1件: COMT   1件: Dopaminergic synapse   2件:
6,
17
 74   Epigallocatechin gallate  2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate;   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299
 75   Epinephrine  4件: Epinephrine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine;   D00095
 D00996
 D02149 
 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
6,
13,
46,
86,
96,
168,
226,
231,
256
 76   Ergoloid mesylate  0件:   D02268   6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   1件:
6
 77   Erythromycin  3件: Erythromycin; Erythromycine; Oral erythromycin;   D00140
 D00851
 D01361
 D02009
 D02184
 D02523
 D02524
 D02525
 D04054 
 -   -   5件:
6,
36,
164,
228,
291
 78   Erythropoietin  4件: Erythropoietin; Recombinant human erythropoietin(rhepo); Erythropoietin human recombinant (eporh); Recombinant human erythropoietin;   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   9件:
2,
6,
13,
22,
46,
47,
70,
95,
96
 79   Escitalopram  3件: Escitalopram; Oral escitalopram; Escitalopram oxalate antidepressant;   D02567
 D07704
 D07913 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
2,
6,
13
 80   Esomeprazole  3件: Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium);   D01984
 D04056
 D07917
 D09339 
 2件: ATP4A, ATP4B   3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299
 81   Eszopiclone  1件: Eszopiclone;   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   3件:
6,
13,
46
 82   Exametazime  2件: Exametazime; Technetium (99mtc) exametazime;   D01109   -   -   1件:
6
 83   Exenatide  3件: Exenatide; Exenatide 10 micrograms; Exenatide 5 micrograms;   D04121   1件: GLP1R   2件: Insulin secretion, Neuroactive ligand-receptor interaction   3件:
6,
193,
233
 84   Famotidine  2件: Famotidine; Famotidine 20 mg;   D00318   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   3件:
6,
46,
86
 85   Febuxostat  1件: Febuxostat;   D01206   1件: XDH   2件: Peroxisome, Purine metabolism   3件:
2,
6,
13
 86   Fesoterodine  1件: Fesoterodine;   D07226   2件: CHRM2, CHRM3   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 87   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 88   Finasteride  1件: Finasteride;   D00321   1件: SRD5A2   1件: Steroid hormone biosynthesis   1件:
6
 89   Fipamezole  7件: Fipamezole; Fipamezole hydrochloride; Fipamezole hydrochloride 30 mg oral disintegrating tablets; Fipamezole hydrochloride 60 mg oral disintegrating tablets; Fipamezole hydrochloride 90 mg oral disintegrating tablets; Fipamezole odt; Fipamezole odt cohort 2;   -   -   -   2件:
6,
17
 90   Flecainide  2件: Flecainide; Flecainide acetate;   D00638
 D07962 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   1件:
6
 91   Florbenazine F-18  0件:   -   -   -   1件:
6
 92   Fludeoxyglucose F-18  0件:   -   -   -   8件:
6,
13,
34,
46,
53,
84,
127,
300
 93   Fludrocortisone  1件: Fludrocortisone;   D00986
 D07967 
 1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
6,
17,
81
 94   Flumazenil  4件: Flumazenil; Pet with 11c-flumazenil; [11c]flumazenil; 11c-flumazenil;   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
13,
17,
18,
206
 95   Flutemetamol  2件: Flutemetamol; Vizamyl (flutemetamol(f-18));   -   -   -   5件:
5,
6,
7,
17,
127
 96   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 97   Foliglurax  1件: Foliglurax;   -   -   -   1件:
6
 98   Fursultiamine  1件: Fursultiamine;   D03319   -   -   1件:
6
 99   GPI-1485  0件:   -   -   -   1件:
6
 100   Gabapentin  7件: Gabapentin; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Transdermal fentanyl matrix, gabapentin; Gabapentin prescriptions;   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   2件: GABAergic synapse, MAPK signaling pathway   7件:
6,
13,
19,
70,
97,
226,
298
 101   Galantamine  2件: Galantamine; Galantamine hydrobromide;   D02173
 D04292 
 1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
127
 102   Ginkgo biloba  2件: Ginkgo biloba; Ginkgo biloba pills sig: 300mg/tid;   -   -   -   3件:
6,
13,
90
 103   Glutathione  10件: Glutathione; Intranasal glutathione - (in)gsh; Reduced glutathione; Reduced glutathione 100mg; Reduced glutathione 200mg; Glutathione sodium; Gsh (glutathione); Inhaled reduced glutathione; Oral glutathione; Oral reduced l-glutathione;   D00014
 D00031 
 -   -   2件:
6,
299
 104   Glycerin  1件: Glycerine;   D00028   -   -   6件:
6,
13,
53,
265,
316,
317
 105   Glycerol phenylbutyrate  1件: Glycerol phenylbutyrate;   D10127   -   -   2件:
6,
251
 106   Glycopyrronium  0件:   D00540
 D10938 
 1件: CHRM3   4件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Neuroactive ligand-receptor interaction   1件:
6
 107   Gold  3件: Gold; Gold nanocrystals; Sodium aurothiomalate (intramuscular gold);   -   -   -   5件:
2,
6,
13,
46,
171
 108   Grapefruit  2件: Grapefruit; Grapefruit juice;   -   -   -   5件:
6,
46,
50,
83,
97
 109   Green tea leaf  1件: Green tea leaf;   D06903   -   -   5件:
6,
17,
28,
46,
96
 110   Heptaminol  2件: Heptaminol; Heptaminol hydrochloride;   D07158   -   -   1件:
6
 111   Hydrocortisone  22件: Hydrocortisone; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Subcutaneous hydrocortisone 10mg; Hydrocortisone sodium phosphate; Hydrocortisone takeda, tabletter; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dual release hydrocortisone (plenadren); Hydrocortisone (solucortef); Hydrocortisone 10mg tablet; Hydrocortisone 20mg tablets; Hydrocortisone modified release capsules; Hydrocortisone sodium acetate; Subcutaneous hydrocortisone; Cortef (hydrocortisone); Hydrocortisone efcortesol & solu-cortef; Hydrocortisone roussel; Solu-cortef (hydrocortisone); Combination oral budesonide and rectal hydrocortisone; Hydrocortisone sodium succinate; Mesalazine with hydrocortisone sodium succinate;   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 112   Hydrocortisone acetate  0件:   D00165   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299
 113   Hydrocortisone succinate  0件:   D01442   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
6,
81,
83
 114   Hydrogen  4件: Hydrogen; 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Lisuride hydrogenmaleate; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt);   -   -   -   5件:
5,
6,
17,
97,
226
 115   ITI-214  1件: Iti-214;   -   -   -   1件:
6
 116   Idebenone  2件: Idebenone; Idebenone 150 mg film-coated tablets;   D01750   -   -   4件:
6,
13,
113,
302
 117   Inosine  2件: Inosine; 1) inosine 5'-monophosphate;   D00054   -   -   4件:
2,
6,
13,
17
 118   Iodide I-123  0件:   -   -   -   2件:
2,
6
 119   Ioflupane I-123  0件:   D10014   -   -   3件:
2,
5,
6
 120   Ipratropium  4件: Ipratropium; Ipratropium bromide (drug); Nebulized combination ipratropium bromide with salbutamol; Nebulized ipratropium bromide;   D02212   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   2件:
6,
86
 121   Iproniazid  1件: Iproniazid;   D02579   2件: MAOA, MAOB   9件: Arginine and proline metabolism, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6
 122   Isoflurane  1件: Isoflurane;   D00545   -   -   1件:
6
 123   Isoxaflutole  0件:   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299
 124   Isradipine  5件: Dynacirc cr (isradipine); Isradipine; Isradipine cr 10mg; Isradipine cr 20mg; Isradipine cr 5mg;   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   1件:
6
 125   Istradefylline  8件: Istradefylline; Istradefylline ( kw-6002); Istradefylline (kw-6002); Istradefylline 20 mg; Istradefylline 20 mg or 40 mg; Istradefylline 40 mg; Kw-6002 (istradefylline); Rifampin 300mg bid + istradefylline 40mg day 8 only;   D04641   1件: ADORA2A   2件: Neuroactive ligand-receptor interaction, Parkinson disease   1件:
6
 126   Ketamine  5件: Ketamine; Esketamine; Esketamine hydrochloride; S-ketamine; S-ketamine & midazolam;   D00711
 D08098 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Calcium signaling pathway, Glutamatergic synapse, Neuroactive ligand-receptor interaction   6件:
6,
13,
70,
113,
156,
215
 127   L-Cysteine  1件: N-acetyl-cysteine;   D00026
 D02326 
 -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296
 128   L-Leucine  1件: L-leucine;   D00030   -   -   7件:
5,
6,
7,
127,
283,
284,
299
 129   L-Tryptophan  0件:   D00020   -   -   1件:
6
 130   Lactobacillus plantarum  3件: Lactobacillus plantarum; Lactobacillus plantarum ps128; Probiotic-lactobacillus plantarum ps128;   -   -   -   2件:
6,
156
 131   Lactose  4件: Lactose; Lactose monohydrate; 2'-fucosyllactose; Lactose in water;   D00046
 D03226 
 -   -   6件:
2,
6,
13,
97,
228,
310
 132   Lenomorelin  0件:   -   -   -   3件:
6,
78,
299
 133   Leptin  5件: Leptin; Hu leptin (a-100); Human recombinant leptin (metreleptin); Metreleptin; R-methuleptin;   -   -   -   2件:
6,
265
 134   Levetiracetam  1件: Levetiracetam;   D00709   1件: SV2A   1件: ECM-receptor interaction   4件:
2,
4,
6,
13
 135   Levodopa  89件: Carbidopa-levodopa; Levodopa; Accordion pill carbidopa/levodopa; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa and levodopa 25mg/100mg; Carbidopa levodopa; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: levodopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 25/100 mg; Intravenous levodopa; Iv levodopa; Levodopa (delivered intravenously); Levodopa (drug), intraduodenal administration; Levodopa (l-dopa); Levodopa (l-dopa) + standard care; Levodopa / benserazid; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa 100 mg a cap; Levodopa 125 mg a cap; Levodopa 150 mg a cap; Levodopa 25mg/100mg; Levodopa 75 mg a cap; Levodopa acute challenge; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa and decarboxylase inhibitor; Levodopa and domperidone; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa cr (controlled release); Levodopa cyclops; Levodopa dc.it fu; Levodopa dispersible; Levodopa infusion; Levodopa mr; Levodopa powder for inhalation; Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa, decarboxylase inhibitor and comt inhibitor; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; Levodopa/benzeraside; Levodopa/benzerazide; Levodopa/carbidopa; Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Levodopa/ddci; Melevodopa; Melevodopa and decarboxylase inhibitor; Nacom levodopa+cardidopa; Nd0612 (levodopa/carbidopa solution); Oral levodopa and carbidopa; Oral levodopa/carbidopa; Rasagiline mesylate with levodopa; Safinamide + levodopa; Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Tvp-1012 (1 mg/day) with levodopa; Tvp-1012 1mg with levodopa; Levodopa test; Levodopa/carbidopa (4:1);   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   4件: Calcium signaling pathway, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   7件:
2,
4,
6,
17,
90,
164,
201
 136   Levomefolic acid  0件:   D09353   -   -   1件:
6
 137   Liatermin  2件: Liatermin; Liatermin (r-methugdnf);   D04727   -   -   1件:
6
 138   Lidocaine  8件: Lidocaine; Local anesthesia (lidocaine hydrochloride); Lidocaine patch 5%; Lidocaine injection 2%; 5% lidocaine/5 mg/ml estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Lidocaine releasing intravesical system - liris®;   D00358
 D02086
 D08127 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   10件:
6,
13,
46,
84,
86,
97,
168,
226,
231,
256
 139   Liraglutide  1件: Liraglutide;   D06404   1件: GLP1R   2件: Insulin secretion, Neuroactive ligand-receptor interaction   3件:
6,
75,
193
 140   Lisuride  6件: Lisuride; Lisuride hydrogenmaleate; Lisuride transdermal system; Lisuride tts 10cm²; Lisuride tts 20cm²; Transdihydrolisuride;   D01462
 D08132 
 3件: DRD2, DRD3, DRD4   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
86
 141   Lixisenatide  1件: Lixisenatide;   D09729   1件: GLP1R   2件: Insulin secretion, Neuroactive ligand-receptor interaction   1件:
6
 142   Loratadine  1件: Loratadine;   D00364   1件: HRH1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   3件:
6,
13,
46
 143   Lovastatin  5件: Lovastatin; Lovastatin 60 mg; Lovastatin ™; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin;   D00359   1件: HMGCR   1件: Terpenoid backbone biosynthesis   10件:
6,
34,
46,
79,
156,
160,
195,
206,
263,
310
 144   Lubiprostone  1件: Lubiprostone;   D04790   1件: CLCN2   1件: Mineral absorption   4件:
6,
13,
290,
299
 145   Magnesium  16件: Magnesium; Magnesium oxide; Magnesium sulfate; Mineral boost (magnesium); Sulfate, magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Magnesium citrate; Sodium picosulfate/magnesium citrate laxative; Omeprazole magnesium; (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium hydroxide; Sodium picosulfate, magnesium oxide and citric acid; Magnesium gluconate; Nexium (esomeprazole magnesium);   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298
 146   Magnesium oxide  2件: Magnesium oxide; Sodium picosulfate, magnesium oxide and citric acid;   D01167   -   -   3件:
6,
166,
291
 147   Maltodextrin  3件: Maltodextrin; Resistant maltodextrin; Maltodextrin fiber supplement;   D02329   -   -   4件:
6,
13,
96,
97
 148   Mannitol  7件: Mannitol; Dp mannitol; Idpm: inhaled dry powder mannitol; Inhaled dry powder mannitol; Inhaled mannitol; Mannitol + pulmozyme; Mannitol inhalation powder;   D00062   -   -   3件:
6,
96,
299
 149   Masitinib  10件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib mesylate; Masitinib 100mg; Masitinib 200mg; Masitinib (ab1010); Masitinib 3 mg; Masitinib 6.0 mg;   D10229   1件: KIT   2件: MAPK signaling pathway, Pathways in cancer   6件:
2,
5,
6,
13,
46,
96
 150   Medical Cannabis  0件:   -   -   -   6件:
2,
6,
13,
90,
96,
97
 151   Melatonin  10件: Melatonin; Melatonin pr; Melatonin(circadin®); 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin cr;   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202
 152   Melevodopa  2件: Melevodopa; Melevodopa and decarboxylase inhibitor;   D07304   -   -   1件:
6
 153   Melperone  2件: Melperone; Melperone hcl;   D07309   1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 154   Memantine  3件: Memantine; Memantine (ebixa); Memantine hydrochloride;   D04905
 D08174 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Alzheimer disease, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
6,
8,
13,
49,
127,
205
 155   Metformin  15件: Metformin; Glucophage (metformin); Metformin/cp-690,550; Metformin hydrochloride; Metformine; Metformine sandoz 850 mg filmomhulde tabletten; 750 mg metformin and 7.5 g l-citrulline daily p.o.; L-citrulline and metformin & l-citrulline; Metformin 500mg; Metformin and metformin & l-citrulline; Metformin (generic); Sitagliptin and metformin; Pioglitazone or metformin; Metformin hcl; Metformine hcl 500 pch;   D00944
 D04966 
 2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   17件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285,
299
 156   Methylphenidate  11件: Methylphenidate; Methylphenidate (mpd); Methylphenidate hydrochloride; Methylphenidate modified release; Methylphenidate modified release 20 mg; Methylphenidate modified release 30 mg; Methylphenidate modified release 40 mg; D-methylphenidate; Methylphenidate (overencapsulated); Methylphenidate 10mg tablets; Methylphenidate, fluoxetin, risperidone;   D01296
 D04999 
 2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   7件:
6,
13,
34,
84,
113,
179,
206
 157   Midazolam  6件: Midazolam; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; Midazolam 2 mg; Midazolam 3 mg;   D00550
 D00696
 D05028 
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298
 158   Midodrine  2件: Midodrine; Midodrine hydrochloride;   D01307
 D08220 
 3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   3件:
6,
17,
58
 159   Minocycline  7件: Minocycline; Glatiramer acetate with minocycline; Minocycline 100 mg film-coated tablets; Minocycline hydrochloride; Combination of minocycline and mtx or mtx alone; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin;   D00850
 D05045 
 -   -   14件:
2,
6,
8,
13,
46,
84,
85,
90,
94,
162,
201,
206,
280,
299
 160   Minodronic acid  1件: Minodronic acid;   -   -   -   4件:
6,
46,
93,
95
 161   Mirabegron  1件: Mirabegron;   D09535   1件: ADRB3   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   3件:
6,
13,
226
 162   Moclobemide  1件: Moclobemide;   D02561   1件: MAOA   9件: Arginine and proline metabolism, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6
 163   Modafinil  5件: Armodafinil; Modafinil; Modafinil 50mg; Over-encapsulated modafinil; Provigil (modafinil);   D01832   -   -   4件:
6,
13,
49,
93
 164   Moxifloxacin  6件: Moxifloxacin; Moxifloxacin infusion; Moxifloxacina cloridrato; Avelox- moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride;   D00874
 D08237 
 -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299
 165   Muscimol  1件: Muscimol;   -   -   -   1件:
6
 166   Nabilone  3件: Nabilone; Nabilone 0.25 mg; Cesamet™ (nabilone);   D05099   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   2件:
6,
13
 167   Nalmefene  1件: Nalmefene;   D05111   3件: OPRD1, OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   1件:
6
 168   Naloxone  8件: Naloxone; Oxycodone/naloxone prolonged release tablets; Naloxone hydrochloride; Oxycodone naloxone prolonged release tablets; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg;   D01340
 D08249 
 3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   2件:
6,
226
 169   Naltrexone  5件: Naltrexone; Naltrexone hydrochloride; 4.5 mg naltrexone; Low dose naltrexone; Naltrexone-hcl;   D02095
 D05113 
 3件: OPRD1, OPRK1, OPRM1   2件: Morphine addiction, Neuroactive ligand-receptor interaction   11件:
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97
 170   Nebicapone  1件: Nebicapone;   -   -   -   1件:
6
 171   Nelotanserin  1件: Nelotanserin;   D09645   1件: HTR2A   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6
 172   Neridronic Acid  1件: Neridronic acid;   -   -   -   1件:
6
 173   Niacin  6件: Niacin; Niacinamide; Dose-establishing study 1 niacin 250mg; Dose-establishing study 1 niacin 500mg; Dose-establishing study 2 niacin 500mg; Niacin first;   D00049   -   -   4件:
6,
78,
79,
265
 174   Nicotinamide  2件: Nicotinamide; Nicotinamide riboside;   D00036   -   -   8件:
5,
6,
13,
46,
49,
53,
67,
162
 175   Nicotinamide riboside  1件: Nicotinamide riboside;   -   -   -   1件:
6
 176   Nicotine  9件: Nicotine; Nicotine gum; Nicotine nasal spray 10 mg/ml (0.5 mg/spray); Nicotine patch; Nicotine transdermal patch; Nicotinell; Nicotinell 17,5 mg/24-stunden-pflaster; Nicotinell 35 mg/24-stunden-pflaster; Transdermal nicotine;   D03365
 D05156
 D05157 
 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
84
 177   Nilotinib  8件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 150 mg; Nilotinib hydrochloride monohydrate; Nilotinib (tasigna);   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   4件: Chronic myeloid leukemia, ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
6,
8,
34,
51,
86
 178   Nitrogen  1件: Nitrogen;   D00083   -   -   5件:
5,
6,
17,
211,
299
 179   Nortriptyline  1件: Nortriptyline;   D00816
 D08288 
 2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
226
 180   Omeprazole  19件: Clartihromycin, amoxicillin, and omeprazole; Esomeprazole; Omeprazole; Dimebon + omeprazole; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Diclofenac + omeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Omeprazole 20mg; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 40 mg; Rifaximin+omeprazole+miralax; Omeprazole 20mg bid; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Nexium (esomeprazole magnesium); Omeprazole 40mg capsule;   D00455
 D01207
 D05259
 D05261 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299
 181   Opicapone  2件: Opicapone; Opicapone (opc);   D10825   1件: COMT   1件: Dopaminergic synapse   1件:
6
 182   Oxybuprocaine  1件: Oxybuprocaine;   D01768
 D08319 
 1件: SCN1A   1件: Dopaminergic synapse   1件:
6
 183   Oxybutynin  3件: Oxybutynin; Oxybutynin and darifenacin; Oxybutynin hydrochloride;   D00465
 D00722 
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 184   Oxycodone  14件: Oxycodone; Oxycodone/naloxone prolonged release tablets; Pr oxycodone; Extended-release oxycodone; Oxycodone by patient-controlled analgesia (pca); Oxycodone hydrochloride; Oxycodone orion; Oxycodone naloxone prolonged release tablets; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; Oxycodone/acetaminophen; Oxycodone depot ”sandoz”, depot tablets;   D03783
 D05312
 D05462 
 3件: OPRD1, OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   7件:
6,
13,
46,
70,
226,
231,
298
 185   Oxygen  10件: Oxygen; Oxygen 40 %; Nitric oxide plus oxygen; Oxygen supplementation; Continuous oxygen; Medical air vs oxygen; Maternal hyperoxygenation; Medical grade oxygen; Perfluorinated gas/oxygen mixture; Helium / oxygen mixed gas inhalation therapy;   D00003   -   -   18件:
5,
6,
17,
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
211,
226,
299,
330
 186   Pardoprunox  2件: Pardoprunox; Pardoprunox hydrochloride;   D09397   3件: DRD2, DRD3, HTR1A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6
 187   Paroxetine  3件: Paroxetine; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp;   D02260
 D02362
 D05374
 D05375 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
6,
13,
46
 188   Perampanel  3件: Perampanel; 2 mg perampanel; 4 mg perampanel;   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   3件:
2,
6,
144
 189   Pergolide  1件: Pergolide;   D00502
 D08339 
 2件: DRD1, DRD2   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   1件:
6
 190   Phenelzine  0件:   D00505
 D08349 
 2件: MAOA, MAOB   9件: Arginine and proline metabolism, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6
 191   Phenylbutyric acid  0件:   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299
 192   Piclozotan  1件: Piclozotan;   -   -   -   1件:
6
 193   Pilocarpine  2件: Pilocarpine; Pilocarpine nitrate 5%;   D00525
 D02200
 D05478 
 2件: CHRM2, CHRM3   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Salivary secretion   3件:
6,
53,
299
 194   Pimavanserin  5件: Active drug: pimavanserin 17mg (2 strength tablets); Pimavanserin; Pimavanserin (acp-103); Pimavanserin tartrate; Pimavanserin tartrate (acp-103);   -   -   -   1件:
6
 195   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 196   Piribedil  2件: Piribedil; Piribedil (clarium);   D07305   2件: DRD2, DRD3   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 197   Pitolisant  2件: Bf2.649 (pitolisant); Pitolisant;   D10749   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6
 198   Pittsburgh Compound B  2件: Pittsburgh compound b; Pittsburgh compound b (c-11 pib);   -   -   -   2件:
6,
127
 199   Pramipexole  25件: Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Pramipexole; R(+) pramipexole dihydrochloride monohydrate; Dopamine agonists (pramipexole, ropirinole); Mirapex (pramipexole); P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Pramipexole 0.125 mg tablets; Pramipexole 0.5 mg tablets; Pramipexole dihydrochloride; Pramipexole dihydrochloride extended-release tablets; Pramipexole dihydrochloride monohydrate; Pramipexole dihydrochloride monohydrate extended release; Pramipexole er; Pramipexole extended release; Pramipexole extended release tablet; Pramipexole immediate release; Pramipexole immediate release tablet; Pramipexole ir; Pramipexole or ropinirole; Pramipexole sr;   D00559
 D05575 
 3件: DRD2, DRD3, DRD4   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   2件:
2,
6
 200   Preladenant  4件: Preladenant; Preladenant 10 mg tablet; Preladenant 2 mg tablet; Preladenant 5 mg tablet;   D09717   1件: ADORA2A   1件: Neuroactive ligand-receptor interaction   1件:
6
 201   Pridopidine  2件: Pridopidine; Pridopidine (90 mg);   D09953   1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
8
 202   Propofol  3件: Propofol; Propofol-lipuro; Intubated with propofol (ip);   D00549   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   8件:
6,
21,
22,
34,
46,
84,
98,
296
 203   Propranolol  5件: Propranolol; Propranolol hcl cf 40 mg tablet; Atenolol or propranolol; Losartan and atenolol or propranolol; Propranolol treatment;   D00483
 D08443 
 3件: ADRB1, ADRB2, ADRB3   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   5件:
6,
158,
167,
227,
278
 204   Pyridostigmine  2件: Pyridostigmine; Pyridostigmine bromide;   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
3,
6,
11,
256
 205   Pyridoxine  4件: Pyridoxine; Pyridoxine 10mg; Pyridoxine 10mg bp; Pyridoxine plus prednisolone;   D02179
 D08454 
 -   -   4件:
6,
49,
93,
145
 206   Quetiapine  2件: Quetiapine; Extended-release quetiapine fumarate;   D00458
 D08456 
 2件: DRD2, HTR2A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
6,
13
 207   Raclopride  2件: Raclopride; 11c-raclopride;   -   -   -   4件:
5,
6,
7,
17
 208   Ramelteon  1件: Ramelteon;   D02689   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   3件:
6,
8,
46
 209   Rasagiline  16件: Rasagiline; Rasagiline mesilate; 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets;   D02562
 D08469
 D10829 
 1件: MAOB   2件: Dopaminergic synapse, Serotonergic synapse   4件:
2,
5,
6,
17
 210   Remifentanil  1件: Remifentanil;   D01177
 D08473 
 1件: OPRM1   1件: Neuroactive ligand-receptor interaction   2件:
6,
70
 211   Repaglinide  2件: Repaglinide; Repaglinide and insulin;   D00594   2件: ABCC8, KCNJ11   3件: ABC transporters, Insulin secretion, Type II diabetes mellitus   2件:
6,
299
 212   Reynoutria multiflora root  0件:   -   -   -   1件:
6
 213   Rifampicin  1件: Rifampicin;   D00211   -   -   7件:
6,
13,
17,
46,
84,
86,
299
 214   Rifaximin  10件: Rifaximin; Rifaximin 550 mg; Rifaximin delayed release (dr); Rifaximin delayed release 400 mg film coated tablet; Rifaximin delayed release tablets; Rifaximin eir; Rifaximin+omeprazole+miralax; Rifaximin-eir; Rifaximina; Rifaximin oral tablet;   D02554   -   -   7件:
6,
65,
94,
96,
97,
99,
296
 215   Rivastigmine  5件: Rivastigmine; Exelon patch (rivastigmine transdermal system); Rivastigmine capsule; Rivastigmine patch 9.5 cm2; Rivastigmine transdermal patch;   D02558
 D03822 
 1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
5,
6,
13
 216   Ropinirole  27件: Hp-3000 (ropinirole hydrochloride patch); Hp-3000(ropinirole hydrochloride patch); Pramipexole or ropinirole; Ropinirole; Ropinirole (as hydrochloride); Ropinirole controlled-release (requip cr) for rls; Ropinirole cr 2mg tablet; Ropinirole cr 8mg tablet; Ropinirole hydrochloride; Ropinirole hydrochloride extended-release tablet; Ropinirole hydrochloride extended-release tablet placebo; Ropinirole hydrochloride prolonged release; Ropinirole immediate release; Ropinirole implant; Ropinirole ir; Ropinirole ir tablets; Ropinirole monotherapy; Ropinirole oral product; Ropinirole pr; Ropinirole pr, 2mg; Ropinirole pr/xr; Ropinirole pr/xr tablets; Ropinirole prolonged release; Ropinirole prolonged release/extended release(pr/xr); Ropinirole xl; Ropinirole xl (formerly cr); Ropinirole/l-dopa;   D00784
 D08489 
 3件: DRD2, DRD3, DRD4   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   3件:
6,
74,
309
 217   Rosuvastatin  6件: Rosuvastatin; Rosuvastatin calcium; Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin 20mg; Rosuvastatin 10 mg;   D01915
 D08492 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299
 218   Rotigotine  10件: Rotigotine; Rotigotine (reference product pr 2.1.1); Rotigotine (test product pr 2.3.1); Rotigotine hydrochloride; Rotigotine nasal spray; Rotigotine transdermal patch; Rotigotine transdermal patch 2mg/24h(10cm2); Rotigotine transdermal patch 4mg/24h (20cm2); Rotigotine transdermal patch 6mg/24h (30cm2); Rotigotine transdermal patch 8mg/24h (40cm2);   D05768   1件: DRD2   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Parkinson disease   1件:
6
 219   Safinamide  9件: Safinamide; Safinamide + levodopa; Safinamide metansolfonato (12 weeks); Safinamide methanesulfonate; Safinamide methanesulfonate 100mg; Safinamide methanesulfonate 150mg; Safinamide methansulfonate; Safinamide, mao-b inhibitor; Xadago (safinamide);   D10158   1件: MAOB   2件: Dopaminergic synapse, Serotonergic synapse   2件:
6,
17
 220   Sage  7件: Sage; Sage leaf; Sage-217; Thn102 dosage a; Thn102 dosage b; Thn102 dosage c; Sage-718;   -   -   -   2件:
6,
8
 221   Saracatinib  1件: Saracatinib;   D09664   2件: ABL1, SRC   3件: Chemokine signaling pathway, ErbB signaling pathway, VEGF signaling pathway   2件:
6,
89
 222   Sarcosine  2件: Sarcosine; Sarcosine capsule;   -   -   -   1件:
6
 223   Sargramostim  3件: Sargramostim; Sargramostim (leukine); Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim);   D05803   1件: CSF2RA   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   6件:
6,
28,
60,
62,
96,
229
 224   Sarizotan  4件: Sarizotan; Sarizotan hc1; Sarizotan hcl; Sarizotan hydrochloride;   -   -   -   2件:
6,
156
 225   Selegiline  3件: Orally disintegrating selegiline (zelapar); Selegiline; Selegiline hcl 5 pch;   D00785
 D03731 
 1件: MAOB   2件: Dopaminergic synapse, Serotonergic synapse   1件:
6
 226   Semaglutide  1件: Semaglutide;   D10025   1件: GLP1R   2件: Insulin secretion, Neuroactive ligand-receptor interaction   1件:
6
 227   Serine  4件: L-serine; Serine; D-serine; D-serine (~2g/day);   D00016   -   -   3件:
2,
6,
86
 228   Sertraline  1件: Sertraline;   D00825
 D02360 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
6,
8,
206
 229   Sevoflurane  3件: Sevoflurane; Intubated with sevoflurane (is); Sevoflurane anesthetics;   D00547   -   -   5件:
6,
21,
22,
98,
296
 230   Sildenafil  25件: Sildenafil; 5% sildenafil cream; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil citrate; Sildenafil therapy; Sildenafil (50 mg); Sildenafil and losartan; 20 mg sildenafil citrate by mouth; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Oral sildenafil; Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil citrate (uk-92,480); Sildenafil singly or in association with bosentan; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; Sildenafil 20 mg tablets; Acute (1 hour) sildenafil; Sildenafil 40mg oral capsule; Sub-chronic (4 weeks) sildenafil;   D02229
 D08514 
 1件: PDE5A   1件: cGMP-PKG signaling pathway   16件:
6,
46,
50,
51,
85,
86,
96,
113,
210,
211,
212,
225,
226,
278,
294,
299
 231   Silodosin  1件: Silodosin;   D01965   1件: ADRA1A   3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
6,
13
 232   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 233   Smilagenin  1件: Smilagenin;   -   -   -   1件:
6
 234   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 235   Sodium oxybate  1件: Sodium oxybate;   D05866   -   -   3件:
6,
120,
149
 236   Solifenacin  2件: Solifenacin; Solifenacin succinate (vesicare);   D01269
 D08522 
 1件: CHRM3   3件: Calcium signaling pathway, Cholinergic synapse, Neuroactive ligand-receptor interaction   1件:
6
 237   Sulfate ion  0件:   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299
 238   Sumanirole  1件: Sumanirole;   -   -   -   1件:
6
 239   Suvorexant  1件: Suvorexant;   D10082   2件: HCRTR1, HCRTR2   1件: Neuroactive ligand-receptor interaction   3件:
5,
6,
13
 240   Tadalafil  11件: Tadalafil; Tadalafil and ambrisentan upfront combination therapy; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafil 20 mg; Tadalafil and sildenafil;   D02008   1件: PDE5A   1件: Purine metabolism   6件:
6,
51,
75,
84,
86,
113
 241   Talampanel  1件: Talampanel;   D02696   4件: GRIA1, GRIA2, GRIA3, GRIA4   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   2件:
2,
6
 242   Tavapadon  0件:   D11431   2件: DRD1, DRD5   1件: Neuroactive ligand-receptor interaction   1件:
6
 243   Technetium Tc-99m exametazime  0件:   D02284   -   -   1件:
6
 244   Terazosin  2件: Terazosin; Terazosin 5 mg;   D00610
 D08569 
 3件: ADRA1A, ADRA1B, ADRA1D   3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6
 245   Tesofensine  3件: 1. tesofensine (ns 2330); Tesofensine; Tesofensine/metoprolol;   -   -   -   2件:
6,
193
 246   Tolcapone  1件: Tolcapone;   D00786   1件: COMT   1件: Dopaminergic synapse   3件:
6,
28,
127
 247   Topiramate  2件: Topiramate; Topiramate (drug);   D00537   29件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5   4件: Calcium signaling pathway, GABAergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   5件:
6,
140,
144,
156,
193
 248   Topramezone  0件:   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299
 249   Tozadenant  5件: Tozadenant; Tozadenant (syn115) 120 mg bid; Tozadenant (syn115) 180 mg bid; Tozadenant (syn115) 240 mg bid; Tozadenant (syn115) 60 mg bid;   D10174   1件: ADORA2A   1件: Neuroactive ligand-receptor interaction   1件:
6
 250   Triamcinolone  10件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonid (lederspan); Triamcinolone hexacetonide; Triamcinolone hexacetonide (lederspan); Triamcinolone acetonide and normal saline solution; Bladder instillation with triamcinolone acetonide; Bladder instillation without triamcinolone acetonide; Bupivacaine & triamcinolone acetonide; Intra plexus triamcinolone and bupivicaine injection;   D00385
 D00983
 D00984
 D00985
 D06216 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   18件:
6,
10,
13,
35,
40,
41,
42,
43,
44,
45,
46,
56,
70,
90,
96,
97,
226,
298
 251   Trihexyphenidyl  2件: Trihexyphenidyl; Primary cervical dystonia (trihexyphenidyl);   D00787
 D08638 
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   2件: Cholinergic synapse, Neuroactive ligand-receptor interaction   2件:
5,
6
 252   Trimethobenzamide  2件: Trimethobenzamide; Trimethobenzamide hydrochloride;   D02733
 D08643 
 -   -   1件:
6
 253   Tropicamide  5件: 0 mg tropicamide; 0.3 mg tropicamide; 1 mg tropicamide; 3 mg tropicamide; Tropicamide;   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   5件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Neuroactive ligand-receptor interaction, Salivary secretion   2件:
6,
19
 254   Tyrosine  2件: L-tyrosine; Tyrosine;   D00022   -   -   3件:
6,
86,
111
 255   Ubidecarenone  0件:   D01065   -   -   12件:
2,
5,
6,
8,
10,
46,
57,
86,
113,
193,
214,
215
 256   Ubiquinol  1件: Ubiquinol;   -   -   -   3件:
6,
8,
17
 257   Uric acid  0件:   -   -   -   1件:
6
 258   Ursodeoxycholic acid  13件: Ursodeoxycholic acid; Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules; Udca (ursodeoxycholic acid); Ursodeoxycholic acid (urso); Ursodeoxycholic acid 300mg capsule; Ursodeoxycholic acid 300mg tablet; Ursodeoxycholic acid capsules; Ursodeoxycholic acid combination of immunosuppressive agents; Norursodeoxycholic acid; Ursodeoxycholic acid (udca); Tauroursoursodeoxycholic acid, brand name tudcabil; Ursodiol (ursodeoxycholic acid, udca);   D00734   1件: NR1H4   1件: Bile secretion   12件:
6,
8,
20,
67,
84,
93,
94,
95,
96,
97,
234,
299
 259   Valerian  1件: Valerian;   -   -   -   1件:
6
 260   Varenicline  2件: Varenicline; Varenicline tartrate;   D08669   2件: CHRNA4, CHRNB2   2件: Cholinergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
18
 261   Venlafaxine  3件: Venlafaxine; Venlafaxine hydrochloride; Efexor xl 75 mg (venlafaxine);   D00821
 D08670 
 2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
46
 262   Vitamin E  8件: Vitamin e; Coenzyme q10 with vitamin e; Vitamin e/selenium; Omega-3 and vitamin e supplementation; Vitamin e 800iu; Vitamin c 10mg/kg vitamin e 10 mg/kg; Vitamin e - tgps; Vitamin e supplement;   D02331   -   -   12件:
2,
6,
13,
20,
46,
49,
90,
96,
97,
206,
299,
317
 263   Warfarin  4件: Warfarin; S-warfarin; The generic name is warfarin and many producers will be involved; Warfarin 10 mg;   D00564
 D01280
 D08682 
 2件: NQO1, VKORC1   1件: Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,